SELEGILINE AS A POTENTIAL COCAINE TREATMENT MEDICATION: BEHAVIORAL EVALUATIONS IN RHESUS MONKEYS AND COMPARISONS WITH OTHER MAO INHIBITORS IN RODENTS
David J. McCann; Nancy K. Mello; S Stevens Negus; Jack Bergman; Michael Forster; Susan Schenk
Author Information: NIDA Medications Development Division, Rockville, MD
| Checking for direct PDF access through Ovid | ||